08/18/2025
7:15 PM | Artiva Biotherapeutics (Issuer)
Horan Christopher (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/18/2025
7:15 PM | Artiva Biotherapeutics (Issuer)
Bush Jennifer (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/18/2025
7:15 PM | Artiva Biotherapeutics (Issuer)
Krishnamohan Neha (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/18/2025
7:15 PM | Artiva Biotherapeutics (Issuer)
Raymon Heather (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/18/2025
7:15 PM | Artiva Biotherapeutics (Issuer)
Aslan Fred (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/17/2025
11:15 PM | Artiva Biotherapeutics (Filer)
| Form EFFECT | |
08/06/2025
4:16 PM | Artiva Biotherapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
07/16/2025
6:02 PM | Artiva Biotherapeutics (Subject)
BlackRock, Inc. (Filed by)
| Form SCHEDULE 13G/A | |
06/26/2025
3:30 PM | Artiva Biotherapeutics (Issuer)
DANIELS BRIAN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/26/2025
3:30 PM | Artiva Biotherapeutics (Issuer)
Miralles Gines Diego (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/26/2025
3:30 PM | Artiva Biotherapeutics (Issuer)
Stoppel Laura (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for ARTV and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Artiva Biotherapeutics and its competitors with MarketBeat's FREE daily newsletter. |
06/26/2025
3:30 PM | Artiva Biotherapeutics (Issuer)
HOUGEN ELIZABETH L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/26/2025
3:30 PM | Artiva Biotherapeutics (Issuer)
Baker Daniel G. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/26/2025
3:30 PM | Artiva Biotherapeutics (Issuer)
MOORE ALISON (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/25/2025
3:02 PM | Artiva Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/08/2025
7:03 AM | Artiva Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/08/2025
7:06 AM | Artiva Biotherapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/28/2025
8:34 PM | Artiva Biotherapeutics (Filer)
| Form DEF 14A | |
04/28/2025
8:36 PM | Artiva Biotherapeutics (Filer)
| Form DEFA14A | |
04/28/2025
8:43 PM | Artiva Biotherapeutics (Filer)
| Form ARS | |
04/23/2025
7:14 PM | Artiva Biotherapeutics (Subject)
BlackRock, Inc. (Filed by)
| Form SCHEDULE 13G | |
03/24/2025
3:09 PM | Artiva Biotherapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/07/2025
3:35 PM | Artiva Biotherapeutics (Issuer)
Aslan Fred (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2025
4:15 PM | Artiva Biotherapeutics (Issuer)
Bush Jennifer (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2025
4:15 PM | Artiva Biotherapeutics (Issuer)
Krishnamohan Neha (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2025
4:15 PM | Artiva Biotherapeutics (Issuer)
Horan Christopher (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2025
4:15 PM | Artiva Biotherapeutics (Issuer)
Graef Thorsten (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2025
4:15 PM | Artiva Biotherapeutics (Issuer)
Raymon Heather (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/29/2025
3:32 PM | Artiva Biotherapeutics (Issuer)
Baker Daniel G. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/29/2025
3:33 PM | Artiva Biotherapeutics (Issuer)
Baker Daniel G. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/29/2025
3:07 PM | Artiva Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/14/2024
3:56 PM | Artiva Biotherapeutics (Subject)
venBio Global Strategic Fund III, L.P. (Filed by)
| Form SC 13G/A | |
10/22/2024
7:14 PM | Artiva Biotherapeutics (Issuer)
MOORE ALISON (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
10/22/2024
7:18 PM | Artiva Biotherapeutics (Issuer)
MOORE ALISON (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/22/2024
3:13 PM | Artiva Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/29/2024
3:16 PM | Artiva Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
MarketBeat All Access